BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8835762)

  • 1. Enhanced expression of cathepsin L in metastatic bone tumors.
    Park IC; Lee SY; Jeon DG; Lee JS; Hwang CS; Hwang BG; Lee SH; Hong WS; Hong SI
    J Korean Med Sci; 1996 Apr; 11(2):144-8. PubMed ID: 8835762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis.
    Husmann K; Muff R; Bolander ME; Sarkar G; Born W; Fuchs B
    Mol Carcinog; 2008 Jan; 47(1):66-73. PubMed ID: 17683065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cathepsin L in human tumors.
    Chauhan SS; Goldstein LJ; Gottesman MM
    Cancer Res; 1991 Mar; 51(5):1478-81. PubMed ID: 1997186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma.
    Dohchin A; Suzuki JI; Seki H; Masutani M; Shiroto H; Kawakami Y
    Cancer; 2000 Aug; 89(3):482-7. PubMed ID: 10931446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer.
    Edgington-Mitchell LE; Rautela J; Duivenvoorden HM; Jayatilleke KM; van der Linden WA; Verdoes M; Bogyo M; Parker BS
    Oncotarget; 2015 Sep; 6(29):27008-22. PubMed ID: 26308073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines.
    Kawamata H; Nakashiro K; Uchida D; Harada K; Yoshida H; Sato M
    Int J Cancer; 1997 Jan; 70(1):120-7. PubMed ID: 8985100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype.
    Krueger S; Kellner U; Buehling F; Roessner A
    Cancer Gene Ther; 2001 Jul; 8(7):522-8. PubMed ID: 11498774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.
    Krueger S; Haeckel C; Buehling F; Roessner A
    Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts.
    Sloane BF; Rozhin J; Moin K; Ziegler G; Fong D; Muschel RJ
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):589-94. PubMed ID: 1515088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer cells express cathepsins B and L but not cathepsins K or H.
    Ishibashi O; Mori Y; Kurokawa T; Kumegawa M
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):69-78. PubMed ID: 10738903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
    Fröhlich E; Möhrle M; Klessen C
    Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas.
    Santamaría I; Velasco G; Cazorla M; Fueyo A; Campo E; López-Otín C
    Cancer Res; 1998 Apr; 58(8):1624-30. PubMed ID: 9563472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin K is the principal protease in giant cell tumor of bone.
    Lindeman JH; Hanemaaijer R; Mulder A; Dijkstra PD; Szuhai K; Bromme D; Verheijen JH; Hogendoorn PC
    Am J Pathol; 2004 Aug; 165(2):593-600. PubMed ID: 15277232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion.
    Cuvier C; Jang A; Hill RP
    Clin Exp Metastasis; 1997 Jan; 15(1):19-25. PubMed ID: 9009102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
    Colella R; Jackson T; Goodwyn E
    Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer.
    Delebecq TJ; Porte H; Zerimech F; Copin MC; Gouyer V; Dacquembronne E; Balduyck M; Wurtz A; Huet G
    Clin Cancer Res; 2000 Mar; 6(3):1086-92. PubMed ID: 10741738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues.
    Dodds RA; Connor JR; Drake FH; Gowen M
    Arthritis Rheum; 1999 Aug; 42(8):1588-93. PubMed ID: 10446855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: an in situ hybridization study.
    Petanceska S; Burke S; Watson SJ; Devi L
    Neuroscience; 1994 Apr; 59(3):729-38. PubMed ID: 8008216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role and behavior of cathepsin B and cathepsin L in gastric cancer].
    Herszényi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Rugge M; Cardin R; Naccarato R; Farinati F
    Orv Hetil; 1995 Jun; 136(25):1315-8. PubMed ID: 7596589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.
    Friedrich B; Jung K; Lein M; Türk I; Rudolph B; Hampel G; Schnorr D; Loening SA
    Eur J Cancer; 1999 Jan; 35(1):138-44. PubMed ID: 10211102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.